Please login to the form below
PMEA 2011: Photo Gallery (thumbnails)
PMEA 2011 - Photo Gallery
You can also view the photos as a slideshow or select an image by reference number from the slideshow page.
To order a high resolution print of an image call +44 (0)1372 414200 or email us quoting the reference number
PMEA 2011 1
PMEA 2011 2
PMEA 2011 3
PMEA 2011 4
PMEA 2011 5
PMEA 2011 6
PMEA 2011 7
PMEA 2011 8
PMEA 2011 9
PMEA 2011 10
PMEA 2011 11
PMEA 2011 12
PMEA 2011 13
PMEA 2011 14
PMEA 2011 15
PMEA 2011 16
PMEA 2011 17
PMEA 2011 18
PMEA 2011 19
PMEA 2011 20
PMEA 2011 21
PMEA 2011 22
PMEA 2011 23
PMEA 2011 24
PMEA 2011 25
PMEA 2011 26
PMEA 2011 27
PMEA 2011 28
PMEA 2011 29
PMEA 2011 30
PMEA 2011 31
PMEA 2011 32
PMEA 2011 33
PMEA 2011 34
PMEA 2011 35
PMEA 2011 36
PMEA 2011 37
PMEA 2011 38
PMEA 2011 39
PMEA 2011 40
PMEA 2011 41
PMEA 2011 42
PMEA 2011 43
PMEA 2011 44
PMEA 2011 45
PMEA 2011 46
PMEA 2011 47
PMEA 2011 48
PMEA 2011 49
PMEA 2011 50
PMEA 2011 51
PMEA 2011 52
PMEA 2011 53
PMEA 2011 54
PMEA 2011 55
PMEA 2011 56
PMEA 2011 57
PMEA 2011 58
PMEA 2011 59
PMEA 2011 60
PMEA 2011 61
PMEA 2011 62
PMEA 2011 63
Sponsors
COVID-19 Updates and Daily News
Featured jobs
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- AM / Senior Account Manager – Healthcare PR - London / Remote
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- FREELANCE Associate Director - Healthcare PR - Remote or London
-
Superb Day Rate &Benefits
-
B2B media account director
-
Competitive salary
- MHRA approves second COVID-19 antibody treatment
- Roche acquires test maker TIB Molbiol
- Sanofi to buy acne specialist Origimm
- Merck enters agreement with Hanmi for investigational NASH drug
- AstraZeneca blocks take-private buyout of Sobi
- Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen hands out $120m upfront for Remedy stroke drug
- Pfizer's 2021 revenue predictions soar to $82bn
- The Pharma Multi-channel Marketing Maturity Model
- Assessing the value of interim analyses in clinical trials
- Booster plans expanded to combat Omicron
PMHub
90TEN
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...
Latest intelligence
- Diversity in clinical trials: looking back at our 2021 blogs
- In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
